US$ 25.63
tirzepatide weight loss percentage surmount trials December Blog Post: Tirzepatide, Worth the Weight? Tirzepatide (ZEPBOUND) Approved for Chronic
Description
In the SURMOUNT-1 trial at the highest dose, lean mass decreased by 5.67 kg or 10.9% from baseline, with only 25.7% of total weight lost coming from lean mass
How does Ozempic work for weight loss

We have UK registered doctors that review and assess every consultation

If protein intake falls too low, the risk of telogen effluvium rises sharply

No unit-to-mg conversion needed

Some patients find that starting on a lower dose or taking anti-nausea measures helps with either form
